Date | Time | Source | Headline | Symbol | Company |
05/17/2024 | 3:00PM | iHub Newswire | FeaturedMusic Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements | | |
04/30/2024 | 8:00AM | GlobeNewswire Inc. | Nautilus Biotechnology Reports First Quarter 2024 Financial Results | NASDAQ:NAUT | Nautilus Biotechnology Inc |
04/11/2024 | 8:00AM | GlobeNewswire Inc. | Nautilus Biotechnology to Announce First Quarter 2024 Financial Results on April 30, 2024 | NASDAQ:NAUT | Nautilus Biotechnology Inc |
03/07/2024 | 12:15AM | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness | NASDAQ:NAUT | Nautilus Biotechnology Inc |
03/06/2024 | 4:39PM | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] | NASDAQ:NAUT | Nautilus Biotechnology Inc |
03/05/2024 | 4:49PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:NAUT | Nautilus Biotechnology Inc |
03/05/2024 | 4:46PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:NAUT | Nautilus Biotechnology Inc |
03/05/2024 | 4:42PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:NAUT | Nautilus Biotechnology Inc |
03/05/2024 | 4:34PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:NAUT | Nautilus Biotechnology Inc |
03/05/2024 | 4:30PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:NAUT | Nautilus Biotechnology Inc |
02/28/2024 | 8:00AM | GlobeNewswire Inc. | Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2023 Financial Results | NASDAQ:NAUT | Nautilus Biotechnology Inc |
02/28/2024 | 7:26AM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:NAUT | Nautilus Biotechnology Inc |
02/28/2024 | 7:25AM | Edgar (US Regulatory) | Form S-3 - Registration statement under Securities Act of 1933 | NASDAQ:NAUT | Nautilus Biotechnology Inc |
02/28/2024 | 7:15AM | Edgar (US Regulatory) | Form S-8 - Securities to be offered to employees in employee benefit plans | NASDAQ:NAUT | Nautilus Biotechnology Inc |
02/28/2024 | 7:04AM | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] | NASDAQ:NAUT | Nautilus Biotechnology Inc |
02/28/2024 | 7:03AM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:NAUT | Nautilus Biotechnology Inc |
02/22/2024 | 8:00AM | GlobeNewswire Inc. | Nautilus Biotechnology to Participate in the TD Cowen 44ᵗʰ Annual Healthcare Conference | NASDAQ:NAUT | Nautilus Biotechnology Inc |
02/07/2024 | 8:00AM | GlobeNewswire Inc. | Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024 | NASDAQ:NAUT | Nautilus Biotechnology Inc |
12/14/2023 | 4:17PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:NAUT | Nautilus Biotechnology Inc |
11/30/2023 | 8:00AM | GlobeNewswire Inc. | Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with US HUPO Computational Proteomics Award | NASDAQ:NAUT | Nautilus Biotechnology Inc |
11/01/2023 | 8:05AM | GlobeNewswire Inc. | Nautilus Biotechnology Appoints Martin Huber, Ph.D., as Vice President of Biochemistry and Flow Cell Development | NASDAQ:NAUT | Nautilus Biotechnology Inc |
10/31/2023 | 4:02PM | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:NAUT | Nautilus Biotechnology Inc |
10/31/2023 | 8:05AM | GlobeNewswire Inc. | Nautilus Biotechnology Reports Third Quarter 2023 Financial Results | NASDAQ:NAUT | Nautilus Biotechnology Inc |
10/11/2023 | 8:05AM | GlobeNewswire Inc. | Nautilus Biotechnology to Announce Third Quarter Financial Results on October 31, 2023 | NASDAQ:NAUT | Nautilus Biotechnology Inc |
09/06/2023 | 7:30AM | GlobeNewswire Inc. | Nautilus Biotechnology to Participate in Upcoming September Investor Conferences | NASDAQ:NAUT | Nautilus Biotechnology Inc |
08/04/2023 | 8:00AM | GlobeNewswire Inc. | Nautilus Biotechnology to Participate in Upcoming August Investor Conferences | NASDAQ:NAUT | Nautilus Biotechnology Inc |
08/02/2023 | 4:03PM | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:NAUT | Nautilus Biotechnology Inc |
08/02/2023 | 7:30AM | GlobeNewswire Inc. | Nautilus Biotechnology Reports Second Quarter 2023 Financial Results | NASDAQ:NAUT | Nautilus Biotechnology Inc |
07/11/2023 | 9:23AM | GlobeNewswire Inc. | Nautilus Biotechnology to Announce Second Quarter Financial Results on August 2, 2023 | NASDAQ:NAUT | Nautilus Biotechnology Inc |
06/21/2023 | 6:03AM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:NAUT | Nautilus Biotechnology Inc |